| Primary |
| Product Used For Unknown Indication |
64.3% |
| Depression |
7.6% |
| Hypertension |
7.6% |
| Affective Disorder |
3.2% |
| Anxiety |
2.2% |
| Major Depression |
2.2% |
| Agitation |
1.6% |
| Insomnia |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Burnout Syndrome |
1.1% |
| Prophylaxis |
1.1% |
| Prostatic Adenoma |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Abnormal Behaviour |
0.5% |
| Back Pain |
0.5% |
| Cellulitis Staphylococcal |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Lice Infestation |
0.5% |
| Lung Disorder |
0.5% |
| Obsessive-compulsive Disorder |
0.5% |
|
| Renal Failure Acute |
10.3% |
| Confusional State |
6.9% |
| Gait Disturbance |
6.9% |
| Hallucination |
6.9% |
| Hypoglycaemia |
6.9% |
| Rash |
6.9% |
| Somnolence |
6.9% |
| Weight Increased |
6.9% |
| Agranulocytosis |
3.4% |
| Deep Vein Thrombosis |
3.4% |
| Dyspnoea |
3.4% |
| Eosinophilia |
3.4% |
| Grand Mal Convulsion |
3.4% |
| Hyperkalaemia |
3.4% |
| Hyperprolactinaemia |
3.4% |
| Hyponatraemia |
3.4% |
| Lymphoedema |
3.4% |
| Mutism |
3.4% |
| Myalgia |
3.4% |
| Neuroleptic Malignant Syndrome |
3.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.9% |
| Product Used For Unknown Indication |
25.1% |
| Depression |
12.3% |
| Hypertension |
5.1% |
| Bipolar Disorder |
4.9% |
| Anxiety |
3.6% |
| Agitation |
3.1% |
| Lung Infection |
2.0% |
| Rheumatoid Arthritis |
1.6% |
| Insomnia |
1.5% |
| Hypercholesterolaemia |
1.4% |
| Infection |
1.4% |
| Abnormal Behaviour |
1.2% |
| Bronchopneumonia |
1.1% |
| Hiv Infection |
1.1% |
| Sciatica |
1.1% |
| Dysthymic Disorder |
0.9% |
| Parkinson's Disease |
0.9% |
| Prophylaxis |
0.9% |
| Brain Neoplasm |
0.8% |
|
| Urinary Retention |
10.4% |
| Renal Failure Acute |
8.3% |
| Eosinophilia |
6.3% |
| Neutropenia |
6.3% |
| Off Label Use |
6.3% |
| Thrombocytopenia |
6.3% |
| Psychomotor Retardation |
5.2% |
| Sepsis |
5.2% |
| Vomiting |
5.2% |
| Hypomania |
4.2% |
| Skin Exfoliation |
4.2% |
| Tremor |
4.2% |
| Vision Blurred |
4.2% |
| Weight Increased |
4.2% |
| Withdrawal Syndrome |
4.2% |
| Hypoglycaemia |
3.1% |
| Overdose |
3.1% |
| Periarthritis |
3.1% |
| Platelet Count Decreased |
3.1% |
| Pulmonary Embolism |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.9% |
| Product Used For Unknown Indication |
20.2% |
| Depression |
11.7% |
| Schizophrenia |
6.3% |
| Hypertension |
6.1% |
| Type 2 Diabetes Mellitus |
3.9% |
| Renal Transplant |
3.6% |
| Mantle Cell Lymphoma |
2.9% |
| Ill-defined Disorder |
2.7% |
| Anxiety |
2.5% |
| Psychotic Disorder |
1.9% |
| Pain |
1.8% |
| Postoperative Care |
1.8% |
| Prophylaxis |
1.8% |
| Insomnia |
1.7% |
| Cardiac Failure |
1.5% |
| Hypothyroidism |
1.3% |
| Atrial Fibrillation |
1.1% |
| Dementia Alzheimer's Type |
1.1% |
| Pneumonia |
1.1% |
|
| Renal Failure |
9.3% |
| Pulmonary Embolism |
6.8% |
| Toxic Skin Eruption |
6.8% |
| Urinary Tract Infection |
6.8% |
| Weight Decreased |
6.8% |
| Suicidal Ideation |
5.9% |
| Thrombocytopenia |
5.9% |
| Vomiting |
5.9% |
| Overdose |
5.1% |
| Somnolence |
5.1% |
| Hypothermia |
4.2% |
| Pyrexia |
4.2% |
| Suicide Attempt |
4.2% |
| Cholestasis |
3.4% |
| Neutropenia |
3.4% |
| Tachycardia |
3.4% |
| Transient Ischaemic Attack |
3.4% |
| Tremor |
3.4% |
| Vasculitis |
3.4% |
| Hepatic Enzyme Increased |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
49.4% |
| Agitation |
14.6% |
| Insomnia |
13.5% |
| Pain |
7.9% |
| Hypertension |
4.5% |
| Major Depression |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Arrhythmia |
1.1% |
| Dementia Alzheimer's Type |
1.1% |
| Depression |
1.1% |
| Diarrhoea |
1.1% |
| Urinary Incontinence |
1.1% |
|
| Insomnia |
36.4% |
| Renal Failure Acute |
18.2% |
| Tendonitis |
18.2% |
| International Normalised Ratio Increased |
9.1% |
| Morbid Thoughts |
9.1% |
| Road Traffic Accident |
9.1% |
|
